RTS names Richard Carpenter mid-Atlantic sales manager

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager.

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager. Carpenter has extensive experience in the scientific instrument market and expands the US field-based sales team.

Prior to joining RTS, Carpenter worked for LabCyte and Tecan, where he became an expert in robotics and liquid handling systems.




You may also like

Manufacturing

Software upgrade for RTS Tube Auditor

Improves screening quality, reduces costs and saves time
Regulatory

Standard proposed to clarify endotoxin testing for single-use systems

The guide will address variability when assessing bacterial endotoxins on large-scale pharmaceutical equipment
Regulatory

AlzeCure's pain project ACD440 granted orphan drug status in the US by the FDA

AlzeCure Pharma announces that the US Food and Drug Administration (FDA) has granted the company's application for orphan drug status for the clinical pain candidate drug ACD440
Manufacturing

Molecular Devices unveils next-generation SpectraMax Multi-Mode Microplate Readers

Honouring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility for a wide range of assays and applications
Manufacturing

Merck launches AAW Workstation to advance lab automation

New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Manufacturing

Siemens recognition for Bürkert enables improved development

The new partnership will extend integration capabilities for OEMs and end users with a focus on valve islands for process industries
Manufacturing

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
Subscribe now